Overview
Tumor necrosis factor receptor 1 associated periodic syndrome, most commonly known by its abbreviation TRAPS, is a rare inherited condition that causes repeated episodes of fever and inflammation throughout the body. It used to be called 'familial Hibernian fever' because it was first described in families of Irish and Scottish descent, though we now know it affects people of all backgrounds. TRAPS is caused by changes (mutations) in a gene called TNFRSF1A, which controls a protein that helps regulate the body's inflammatory response. When this gene does not work properly, the immune system becomes overactive and triggers episodes of fever and inflammation that can last days to weeks at a time. During a flare, people with TRAPS may experience high fevers, severe abdominal pain, chest pain, muscle aches, skin rashes, and swelling around the eyes. These episodes can be very disabling and unpredictable. Between attacks, many people feel relatively well, though some have ongoing low-level inflammation. Treatment has improved significantly in recent years. Anti-inflammatory medications, including corticosteroids, have long been used to shorten attacks. Biologic therapies that target specific parts of the immune system — especially a drug called canakinumab (Ilaris), which is FDA-approved for TRAPS — have been a major advance. Another biologic, etanercept, is sometimes used but with variable results. The main long-term concern is a complication called amyloidosis, where inflammatory proteins build up in organs, particularly the kidneys. With proper monitoring and treatment, many people with TRAPS can manage their symptoms and reduce this risk.
Key symptoms:
Recurring high fevers lasting days to weeksSevere abdominal pain and crampingChest pain, sometimes with difficulty breathingMuscle pain and tenderness, often moving from one area to anotherSkin rash that may be red, patchy, or migratorySwelling and puffiness around the eyes (periorbital edema)Joint pain and swellingSwollen lymph nodesHeadacheFatigue and general feeling of being unwell during attacksNausea and vomitingScrotal pain and swelling in males
Clinical phenotype terms (40)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
3 eventsNeveen Abd El Maksoad Kohaf — NA
Kun-Ta Chou
Universitaire Ziekenhuizen KU Leuven — PHASE4
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableILARIS
indicated for the treatment of Tumor Necrosis Factor (TNF) Receptor Associated Periodic Syndrome (TRAPS) in adult and pediatric patients
Clinical Trials
View all trials with filters →No actively recruiting trials found for Tumor necrosis factor receptor 1 associated periodic syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Tumor necrosis factor receptor 1 associated periodic syndrome.
Community
No community posts yet. Be the first to share your experience with Tumor necrosis factor receptor 1 associated periodic syndrome.
Start the conversation →Latest news about Tumor necrosis factor receptor 1 associated periodic syndrome
Disease timeline:
New recruiting trial: TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
A new clinical trial is recruiting patients for Tumor necrosis factor receptor 1 associated periodic syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific mutation do I have in the TNFRSF1A gene, and what does that mean for my risk of complications like amyloidosis?,Should my family members be tested for the same mutation?,Is canakinumab (Ilaris) the right treatment for me, and how will we know if it is working?,How often should I have blood and urine tests to check for kidney damage or amyloidosis?,What should I do at home when a flare starts — is there a rescue treatment plan?,Are there any clinical trials I should know about for TRAPS?,What are the long-term risks if my inflammation is not fully controlled?
Common questions about Tumor necrosis factor receptor 1 associated periodic syndrome
What is Tumor necrosis factor receptor 1 associated periodic syndrome?
Tumor necrosis factor receptor 1 associated periodic syndrome, most commonly known by its abbreviation TRAPS, is a rare inherited condition that causes repeated episodes of fever and inflammation throughout the body. It used to be called 'familial Hibernian fever' because it was first described in families of Irish and Scottish descent, though we now know it affects people of all backgrounds. TRAPS is caused by changes (mutations) in a gene called TNFRSF1A, which controls a protein that helps regulate the body's inflammatory response. When this gene does not work properly, the immune system be
How is Tumor necrosis factor receptor 1 associated periodic syndrome inherited?
Tumor necrosis factor receptor 1 associated periodic syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Tumor necrosis factor receptor 1 associated periodic syndrome?
1 specialists and care centers treating Tumor necrosis factor receptor 1 associated periodic syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.